ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Universal Stainless & Alloy Products, Inc. (Nasdaq - USAP), Patterson Companies, Inc. (Nasdaq - PDCO), Cross Country Healthcare, Inc. (Nasdaq – CCRN), EnLink

BALA CYNWYD, Pa., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Patterson Companies, Inc. (Nasdaq - PDCO)

Under the terms of the agreement, Patterson Companies will be acquired by Patient Square Capital for $31.35 per share in an all-cash transaction valued at approximately $4.1 billion, including the refinancing of Patterson’s receivables facilities. The investigation concerns whether the Patterson Companies Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal offers fair value to the Company’s shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/patterson-companies-inc-nasdaq-pdco/

Universal Stainless & Alloy Products, Inc. (Nasdaq - USAP)

Under the terms of the agreement, Universal will be acquired by Aperam for $45.00 per share in an all-cash transaction. The investigation concerns whether the Universal Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal offers fair value to the Company’s shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/universal-stainless-alloy-products-inc-nasdaq-usap/.

Cross Country Healthcare, Inc. (Nasdaq – CCRN)

Under the terms of the agreement, Cross Country will be acquired by Aya Healthcare for $18.61 per share in cash for each Cross Country share. The investigation concerns whether the Cross Country Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Aya Healthcare is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/cross-country-healthcare-inc-nasdaq-ccrn/.

EnLink Midstream, LLC (NYSE – ENLC)

Under the terms of the Merger Agreement, EnLink be acquired by ONEOK, Inc. (NYSE - OKE) (“ONEOK”). Each outstanding common unit of EnLink that ONEOK does not already own will be converted into 0.1412 shares of ONEOK common stock. The investigation concerns whether the EnLink Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether ONEOK is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/enlink-midstream-llc-nyse-enlc/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.